Expressive Writing for Resilience in Adult Cancer Survivors.

Duke University1 site in 1 country14 target enrollmentJuly 19, 2019

ConditionsCancer Survivors

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Cancer Survivors
Sponsor: Duke University
Enrollment: 14
Locations: 1
Primary Endpoint: Change in resilience as measured by the Connor-Davidson Resilience Scale
Status: Completed
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to determine whether a 1-day expressive writing intervention for adult cancer survivors improves resilience scores as measured by the Connor-Davidson Resilience Scale (CD-RISC).

Detailed Description

Registry

clinicaltrials.gov

Start Date

July 19, 2019

End Date

May 14, 2020

Last Updated

5 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Duke University

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Have ever received a cancer diagnosis
•Have completed cancer treatment (e.g., surgery, radiation, or chemotherapy)
•Are able to speak, read, write, and understand English
•Are cognitively able to provide consent
•Are able to travel to Durham to participate in the 1-day writing intervention

Exclusion Criteria

•Cancer diagnosis was skin cancer that did not require additional treatment after surgical removal

Outcomes

Primary Outcomes

Change in resilience as measured by the Connor-Davidson Resilience Scale

Time Frame: Baseline, 6 months

This 25-item scale addresses resilience, and has been studied in a variety of populations. Resilience is considered as the capacity to overcome adversity.

Secondary Outcomes

Change in quality of life as measured by the Quality of Life Patient/Cancer Survivor Version (QOL-CSV)(Baseline, 6 months)
Change in perceived stress as measured by Perceived Stress Scale (PSS-10)(Baseline, 6 months)
Post-writing survey(1 day (collected during the 1-day intervention))
Change in depression as measured by Center for Epidemiological Studies Depression Scale Revised (CESD-R)(Baseline, 6 months)
Qualitative follow-up questionnaire(6 months)